Conavi Medical Corp.
CNVIF
$0.33
$0.000.61%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -91.68% | 27.29% | 2.46% | 69.23% | -23.87% |
| Total Depreciation and Amortization | -0.60% | 2.61% | -2.47% | 24.86% | -34.03% |
| Total Amortization of Deferred Charges | -5.38% | 4.00% | -3.10% | -81.28% | -- |
| Total Other Non-Cash Items | 365.22% | 43.43% | 2.46% | -115.56% | 134.03% |
| Change in Net Operating Assets | 81.73% | -1,501.97% | -2.46% | -83.56% | -50.11% |
| Cash from Operations | 35.51% | -30.13% | 2.46% | -34.94% | 18.13% |
| Capital Expenditure | -86.05% | 77.95% | 2.50% | 82.85% | -47.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -2.46% | 3,963.77% | -39.11% |
| Cash from Investing | -1,588.37% | -100.34% | -2.46% | 969.54% | -45.47% |
| Total Debt Issued | -- | -- | -- | -- | -24.31% |
| Total Debt Repaid | 29.67% | -6.60% | 0.00% | -136.18% | 23.77% |
| Issuance of Common Stock | -- | 140.03% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.35% | -- | -- | -- | -- |
| Cash from Financing | -102.03% | 302.21% | -2.46% | 34.68% | -24.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.35% | 3,443.64% | -2.47% | 122.31% | -12.23% |